Previous 10 | Next 10 |
Phoenix, Arizona--(Newsfile Corp. - June 1, 2022) - The Stock Day Podcast recently welcomed Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or "the Company"), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and specialty testing se...
Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty testing services to the worldwide biotechnology and other industries. The company today announced that Emerging Techno...
SOUTH EASTON, MA / ACCESSWIRE / May 24, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company") today announced that Emerging Technology Insider, a leading global source for business and financial opportunities of technology companies, has released a new TechTalks video inte...
Pressure BioSciences (OTCQB: PBIO) , a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and specialty services to the worldwide biopharmaceuticals, cosmetics, nutraceuticals, agrochem, and food & beverage industries, is reporti...
Pressure BioSciences press release (OTC:PBIO): Q1 GAAP EPS of -$0.48. Revenue of $0.48M (-14.3% Y/Y). For further details see: Pressure BioSciences GAAP EPS of -$0.48, revenue of $0.48M
Focused on the Successful Launch of its "Early Access Program" for the UST Platform, Company Already Negotiating with Four Potential Customers for Nanoemulsion Processing in Nutraceuticals and Cosmetics Investor Call Scheduled for Thursday, May 19, 2022 at 4:30 p.m. ET SOUTH EASTON,...
Pressure BioSciences (OTCQB: PBIO) , a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and specialty services to the worldwide biopharmaceuticals, cosmetics, nutraceuticals, agrochem, and food & beverage industries, has signed...
Company Signs Development & Manufacturing Agreement with Safer Medical of Montana for Formulation, Pilot Batches, and Commercial Production of CBD Topical Spray for Pain Reduction SOUTH EASTON, MA / ACCESSWIRE / May 4, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Co...
Pressure BioSciences (OTCQB: PBIO) , a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and specialty services to the worldwide biopharmaceuticals, cosmetics, nutraceuticals, agrochem, and food & beverage industries, will be pr...
Company Invites Investors, Analysts, and Advisors to Attend Its In-Person and Webcast Presentation on Wednesday, May 4, 2022 at 11:30am PDT SOUTH EASTON, MA / ACCESSWIRE / May 3, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company"), a leader in the development and sa...
News, Short Squeeze, Breakout and More Instantly...
Pressure BioSciences Inc Company Name:
PBIO Stock Symbol:
OTCMKTS Market:
Pressure BioSciences Inc Website:
Pressure BioSciences (OTCQB: PBIO) , a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemulsion products and services across global industries, today announced a partnership with Vita-Forte, the larg...
CANTON, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” or the “Company”), a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemul...
Pressure BioSciences (OTCQB: PBIO) , a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables and specialty process development and testing services across global industries, today announced that it will host a teleconference to update investors an...